OBJECTIVE: To evaluate the distribution and determinants of myocardial perfusion grade (MPG) following late recanalization of persistently occluded infarct-related arteries (IRA). BACKGROUND:MPG reflects microvascular integrity. It is an independent prognostic factor following myocardial infarction, but has been studied mainly in the setting of early reperfusion. The occluded artery trial (OAT) enrolled stable patients with persistently occluded IRAs beyond 24 hr and up to 28 days post-MI. METHODS:Myocardial blush was assessed using TIMI MPG grading in 261 patients with TIMI 3 epicardial flow following IRA PCI. Patients demonstrating impaired (0-1) versus preserved (2-3) MPG were compared with regard to baseline clinical and pre-PCI angiographic characteristics. RESULTS:Impaired MPG was observed in 60 of 261 patients (23%). By univariate analysis, impaired MPG was associated with failed fibrinolytic therapy, higher heart rate, lower systolic blood pressure, lower ejection fraction, LAD occlusion, absence of collaterals (P < 0.01) and ST elevation MI, lower diastolic blood pressure, and higher systolic sphericity index (P < 0.05). By multivariable analysis, higher heart rate, LAD occlusion, absence of collaterals and higher systolic sphericity index (P < 0.01), and lower systolic blood pressure (P < 0.05) were independently associated with impaired MPG. CONCLUSION: Preserved microvascular integrity was present in a high proportion of patients following late recanalization of occluded IRAs post-MI. Presence of collaterals was independently associated with preserved MPG and likely accounted for the high frequency of preserved myocardial perfusion in this clinical setting. Impaired MPG was associated with baseline clinical and angiographic features consistent with larger infarct size. (c) 2008 Wiley-Liss, Inc.
RCT Entities:
OBJECTIVE: To evaluate the distribution and determinants of myocardial perfusion grade (MPG) following late recanalization of persistently occluded infarct-related arteries (IRA). BACKGROUND: MPG reflects microvascular integrity. It is an independent prognostic factor following myocardial infarction, but has been studied mainly in the setting of early reperfusion. The occluded artery trial (OAT) enrolled stable patients with persistently occluded IRAs beyond 24 hr and up to 28 days post-MI. METHODS:Myocardial blush was assessed using TIMI MPG grading in 261 patients with TIMI 3 epicardial flow following IRA PCI. Patients demonstrating impaired (0-1) versus preserved (2-3) MPG were compared with regard to baseline clinical and pre-PCI angiographic characteristics. RESULTS: Impaired MPG was observed in 60 of 261 patients (23%). By univariate analysis, impaired MPG was associated with failed fibrinolytic therapy, higher heart rate, lower systolic blood pressure, lower ejection fraction, LAD occlusion, absence of collaterals (P < 0.01) and ST elevation MI, lower diastolic blood pressure, and higher systolic sphericity index (P < 0.05). By multivariable analysis, higher heart rate, LAD occlusion, absence of collaterals and higher systolic sphericity index (P < 0.01), and lower systolic blood pressure (P < 0.05) were independently associated with impaired MPG. CONCLUSION: Preserved microvascular integrity was present in a high proportion of patients following late recanalization of occluded IRAs post-MI. Presence of collaterals was independently associated with preserved MPG and likely accounted for the high frequency of preserved myocardial perfusion in this clinical setting. Impaired MPG was associated with baseline clinical and angiographic features consistent with larger infarct size. (c) 2008 Wiley-Liss, Inc.
Authors: C M Gibson; C P Cannon; S A Murphy; K A Ryan; R Mesley; S J Marble; C H McCabe; F Van De Werf; E Braunwald Journal: Circulation Date: 2000-01-18 Impact factor: 29.690
Authors: Vladimír Dzavík; Christopher E Buller; Gervasio A Lamas; James M Rankin; G B John Mancini; Warren J Cantor; Ronald J Carere; John R Ross; Deborah Atchison; Sandra Forman; Boban Thomas; Pawel Buszman; Carlos Vozzi; Anthony Glanz; Eric A Cohen; Peter Meciar; Gerald Devlin; Alice Mascette; George Sopko; Genell L Knatterud; Judith S Hochman Journal: Circulation Date: 2006-11-14 Impact factor: 29.690
Authors: Jun-ichi Kotani; Gary S Mintz; Jerzy Pregowski; Lukasz Kalinczuk; Augusto D Pichard; Lowell F Satler; William O Suddath; Ron Waksman; Neil J Weissman Journal: Am J Cardiol Date: 2003-09-15 Impact factor: 2.778
Authors: Judith S Hochman; Gervasio A Lamas; Christopher E Buller; Vladimir Dzavik; Harmony R Reynolds; Staci J Abramsky; Sandra Forman; Witold Ruzyllo; Aldo P Maggioni; Harvey White; Zygmunt Sadowski; Antonio C Carvalho; Jamie M Rankin; Jean P Renkin; P Gabriel Steg; Alice M Mascette; George Sopko; Matthias E Pfisterer; Jonathan Leor; Viliam Fridrich; Daniel B Mark; Genell L Knatterud Journal: N Engl J Med Date: 2006-11-14 Impact factor: 91.245
Authors: James E Udelson; Camille A Pearte; Carey D Kimmelstiel; Mariusz Kruk; Joseph A Kufera; Sandra A Forman; Anna Teresinska; Bartosz Bychowiec; Jose Antonio Marin-Neto; Thomas Höchtl; Eric A Cohen; Paulo Caramori; Benita Busz-Papiez; Christopher Adlbrecht; Zygmunt P Sadowski; Witold Ruzyllo; Debra J Kinan; Gervasio A Lamas; Judith S Hochman Journal: Am Heart J Date: 2011-03 Impact factor: 4.749
Authors: C Michael Gibson; Sabina A Murphy; Ajay J Kirtane; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald Journal: J Am Coll Cardiol Date: 2004-09-01 Impact factor: 24.094
Authors: Gregg W Stone; Simon R Dixon; Cindy L Grines; David A Cox; John G Webb; Bruce R Brodie; John J Griffin; Jack L Martin; Martin Fahy; Roxana Mehran; Todd D Miller; Raymond J Gibbons; William W O'Neill Journal: Am J Cardiol Date: 2007-08-17 Impact factor: 2.778
Authors: Giuseppe De Luca; Arnoud W J van 't Hof; Menko-Jan de Boer; Jan Paul Ottervanger; Jan C A Hoorntje; A T Marcel Gosselink; Jan-Henk E Dambrink; Felix Zijlstra; Harry Suryapranata Journal: Eur Heart J Date: 2004-06 Impact factor: 29.983
Authors: J P S Henriques; F Zijlstra; J P Ottervanger; M-J de Boer; A W J van 't Hof; J C A Hoorntje; H Suryapranata Journal: Eur Heart J Date: 2002-07 Impact factor: 29.983
Authors: Terje K Steigen; Christopher E Buller; G B John Mancini; Vinod Jorapur; Warren J Cantor; James M Rankin; Boban Thomas; John G Webb; Shari S Kronsberg; Deborah J Atchison; Gervasio A Lamas; Judith S Hochman; Vladimír Džavík Journal: Circ Cardiovasc Interv Date: 2010-11-09 Impact factor: 6.546
Authors: Mariusz Kruk; Christopher E Buller; James Enlou Tcheng; Vladimir Dzavík; Venugopal Menon; G B John Mancini; Sandra A Forman; Peter Kurray; Benita Busz-Papiez; Gervasio A Lamas; Judith S Hochman Journal: Am J Cardiol Date: 2010-01-01 Impact factor: 2.778